In this segment, Dr Luskin examines how patient-related factors influence treatment decisions in blastic plasmacytoid ...
Blueprint Medicines BPMC announced positive top-line results from the Part 2 of PIONEER clinical trial of AYVAKIT (avapritinib) in patients with non-advanced systemic mastocytosis (SM). The Part 2 of ...
No single definition of cytokine storm or the cytokine release syndrome is widely accepted, and there is disagreement about how these disorders differ from an appropriate inflammatory response. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback